CoChat
Sign Up
Cited by 171

The DOI matches its Crossref record.

Evidence for Chlamydia trachomatis as a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer in Brazil and the Philippines

Smith, Jennifer S., Muñoz, Nubia, Herrero, Rolando, Eluf‐Neto, José, Ngelangel, Corazon, Franceschi, Silvia, Bosch, F. Xavier, Walboomers, Jan M. M., Peeling, Rosanna W.·2002·The Journal of Infectious Diseases
DOI 10.1086/338569
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/338569

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. Puolakkainen M, Ukkonen P, Saikku P. The seroepidemiology of chlamy- diae in Finland over the period 1971 to 1987. Epidemiol Infect 1989; 102:287-95.
  2. Schachter J, Hill EC, King EB, Coleman VR, Jones P, Meyer KF. Chlamydial infection in women with cervical dysplasia. Am J Obstet Gynecol 1975; 123:753-7.
  3. Kiviat N, Paavonen J, Wolner-Hanssen P, et al. Histologic manifestations of chlamydial cervicitis. In: Oriel D, Ridgway G, Schachter J, Taylor- Robinson D, Ward M, eds. Chlamydial infections: proceedings of the 6th International Symposium on Human Chlamydial Infections. Cam- bridge, UK: Cambridge University Press, 1986:209-12.
  4. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell cul- ture to a paradigm for chlamydial pathogenesis. Microb Rev 1994;58: 686-99.
  5. de Sanjose ´S, Mun ˜oz N, Bosch FX, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994; 56: 358-63.
  6. Ferrera A, Baay MF, Herbrink P, Figueroa M, Velema JP, Melchers WJ. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 1997; 73:781-5.
  7. Eluf-Neto J, Booth M, Mun ˜oz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69:114-9.
  8. Ngelangel C, Mun ˜oz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90: 43-9.
  9. Wang SP, Grayston JT. Microimmunofluorescence antibody responses in Chlamydia trachomatis infection: a review. In: Mardh PA, Holmes KK, Oriel JD, et al., eds. Chlamydial infections. Amsterdam: Elsevier Biomedical Press, 1982:301-16.
  10. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
  11. Smith JS, Herrero R, Mun ˜oz N, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-aged women in Brazil and the Philippines. Sex Transm Dis 2001; 28:187-94.
  12. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
  13. Schmauz R, Okong P, de Villiers EM, et al. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 1989; 43:805-9.
  14. Dillner J, Lenner P, Lehtinen M, et al. A population-based seroepidemio- logical study of cervical cancer. Cancer Res 1994; 54:134-41.
  15. Jha PK, Beral V, Peto J, et al. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 1993; 341:1116-8.
  16. Hakama M, Lehtinen M, Knekt P, et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol 1993; 137:166-70.
  17. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85:35-9.
  18. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285:47-51.
  19. Lehtinen M, Dillner J, Knekt P, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996;312:537-9.
  20. Gravitt PE, Castle PE. Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA 2001; 285:1703-4.
  21. Landis JR, Koch GG. The measurement of observer agreement for cate- gorical data. Biometrics 1977; 33:159-74.
  22. Puolakkainen M, Vesterinen E, Purola E, Saikku P, Paavonen J. Per- sistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol 1986; 23:924-8.
  23. Patnode D, Wang SP, Grayston JT. Persistence of Chlamydia pneumo- niae, strain TWAR micro-immunofluorescent antibody. In: Bowie WR, ed. Chlamydial infections. Cambridge, UK: Cambridge University Press, 1990:406-10.
  24. Schachter J. Human Chlamydia psittaci infection. In: Oriel D, Ridgway G, Schachter J, Taylor-Robinson D, Ward M, eds. Chlamydial infections: proceedings of the 6th International Symposium on Human Chlamydial Infections. Cambridge, UK: Cambridge University Press, 1986:311-20.
  25. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61:306-11.
  26. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually transmitted diseases. New York: McGraw-Hill, 1998:407-18.
  27. Cevenini R, Costa S, Rumpianesi F, et al. Cytological and histopathologi- cal abnormalities of the cervix in genital Chlamydia trachomatis infec- tions. Br J Vener Dis 1981; 57:334-7.
  28. Paavonen J, Stevens CE, Wolner-Hanssen P, et al. Colposcopic manifes- tations of cervical and vaginal infections. Obstet Gynecol Surv 1988; 43:373-81.
  29. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The signifi- cance of squamous metaplasia in the development of low grade squa- mous intraepithelial lesions in young women. Cancer 1999; 85:1139-44.
  30. Fan T, Lu H, Hu H, et al. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase acti- vation. J Exp Med 1998; 187:487-96.
  31. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000;60: 184-90.

Cited by

Metadata

Authors
Smith, J. S., Muñoz, N., Herrero, R., Eluf‐Neto, J., Ngelangel, C., Franceschi, S., Bosch, F. X., Walboomers, J. M. M., & Peeling, R. W.
Venue
The Journal of Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
2002-02
Volume
185
Issue
3
Pages
324-331
ISSN
  • 0022-1899
  • 1537-6613
DOI
10.1086/338569
Cited by
171
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review